Literature DB >> 8512808

Caffeine potentiates the lethality of tumour necrosis factor in cancer cells.

J E Belizario1, J L Tilly, S W Sherwood.   

Abstract

In this study we have investigated the interaction of caffeine, a prototypic methylxanthine, and TNF on the induction of cell death in mouse and human cell lines during progression from G1 to successive phases of the cell cycle. Exposure of cells to TNF (0.1-100 ng ml-1) as single agent for 48 h caused low or no lethality. The rates of cell death increased significantly when cells cultured with TNF for 24 h were exposed to caffeine (2.5-20 mM). The magnitude of the enhancement by caffeine was TNF and caffeine dose-dependent. The most effective response to this combination was observed in the mouse cell lines, WEHI and L929, followed by the human cell lines, HeLa, A375 and MCF-7, respectively. In L929 cells, TNF treatment did not inhibit DNA synthesis during the first S phase of the cell cycle (20-24 h), but it did block the progress toward a second S phase, indicating the cells were arrested at G2 phase or mitosis. Caffeine had great enhancer effect on L929 cells exposed to TNF for 24 h, but the effect was reduced in cells with either less than 24 h or greater than 28 h of exposure. L929 cells stimulated with TNF died via apoptosis, as judged by both morphological criteria and the occurrence of internucleosomal DNA cleavage. Exposure of TNF-treated cells to caffeine caused a greater increase in the proportion of apoptotic cells as well as the extent of internucleosomal DNA fragmentation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512808      PMCID: PMC1968497          DOI: 10.1038/bjc.1993.230

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia.

Authors:  M A Barry; C A Behnke; A Eastman
Journal:  Biochem Pharmacol       Date:  1990-11-15       Impact factor: 5.858

2.  Cell line-specific differences in the control of cell cycle progression in the absence of mitosis.

Authors:  A L Kung; S W Sherwood; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Apoptosis. The role of the endonuclease.

Authors:  M J Arends; R G Morris; A H Wyllie
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

4.  Phase I trial of escalating pentoxifylline dose with constant dose thiotepa.

Authors:  B J Dezube; J P Eder; A B Pardee
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

5.  Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.

Authors:  J E Belizario; C A Dinarello
Journal:  Cancer Res       Date:  1991-05-01       Impact factor: 12.701

6.  Cytotoxicity by tumor necrosis factor is linked with the cell cycle but does not require DNA synthesis.

Authors:  F D Coffman; D L Haviland; L M Green; C F Ware
Journal:  Growth Factors       Date:  1989       Impact factor: 2.511

7.  Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.

Authors:  Z Baloch; S Cohen; F D Coffman
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

8.  Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence.

Authors:  H Zheng; J J Crowley; J C Chan; H Hoffmann; J R Hatherill; A Ishizaka; T A Raffin
Journal:  Am Rev Respir Dis       Date:  1990-11

9.  Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.

Authors:  K Keyomarsi; L Sandoval; V Band; A B Pardee
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

10.  Molecular mechanisms of DNA repair inhibition by caffeine.

Authors:  C P Selby; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

View more
  4 in total

1.  Cell fusion to study nuclear-cytoplasmic interactions in endothelial cell apoptosis.

Authors:  V A Polunovsky; D H Ingbar; M Peterson; P B Bitterman
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

2.  Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector.

Authors:  Dennis Kobelt; Jutta Aumann; Manuel Schmidt; Burghardt Wittig; Iduna Fichtner; Diana Behrens; Margit Lemm; Greta Freundt; Peter M Schlag; Wolfgang Walther
Journal:  Mol Oncol       Date:  2014-01-18       Impact factor: 6.603

3.  Activation of cyclin A-dependent protein kinases during apoptosis.

Authors:  W Meikrantz; S Gisselbrecht; S W Tam; R Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 4.  Apoptosis: clinical relevance and pharmacological manipulation.

Authors:  U Thatte; S Dahanukar
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.